PROGENE - National Study on Prostate Cancer

Head :
Cussenot Olivier, CEREPP

Last update : 07/15/2014 | Version : 1 | ID : 60134

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name National Study on Prostate Cancer
Sign or acronym PROGENE
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL: 27/06/2001
General Aspects
Medical area Cancer research
Health determinants Genetic
Social and psychosocial factors
Others (details) Prostate cancer
Keywords anatomopathological, data, weight, height, Health episodes, clinical, family history
Scientific investigator(s) (Contact)
Name of the director Cussenot
Surname Olivier
Address 75020 PARIS
Phone + 33 (0)1 56 01 64 95
Email olivier.cussenot@tnn.aphp.fr
Unit CEREPP
Organization APHP
Collaborations
Funding
Funding status Mixed
Details AP-HP CEREPP
Governance of the database
Sponsor(s) or organisation(s) responsible CEREPP
Organisation status Private
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Cohort study
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Inclusion method: Prospective Other bodies active in creating this cohort: CHU, CHG, INDEPENDENT PHYSICIANS, CNAM
Database objective
Main objective General objective: To initiate a collection of informative families with at least one member with prostate cancer and apparently health subjects. Secondary objectives: - To identify genes for predisposition and susceptibility to prostate cancer - To identify genetic markers associated with recurrence after treatment - To develop a genetic screening test for these pathologies
Inclusion criteria Men with histologically verified prostate cancer Healthy subjects with PSA levels below 4 ng/ml
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Population covered Sick population
Gender Male
Geography area National
Detail of the geography area France
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 06/2001
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 5965
Data
Database activity Data collection completed
Type of data collected Clinical data
Declarative data
Biological data
Clinical data (detail) Direct physical measures
Medical registration
Declarative data (detail) Paper self-questionnaire
Biological data (detail) Type of samples taken: Blood and/or saliva and/or urine
Presence of a biobank Yes
Contents of biobank Serum
DNA
Details of biobank content Serum bank, DNA bank
Health parameters studied Health event/morbidity
Health event/mortality
Procedures
Data collection method Self-administered questionnaire: Entry from a paper questionnaire (Manual input) Clinical examination: Handwritten (Manual input) Biological Analysis: Handwritten (Manual input)
Participant monitoring Yes
Details on monitoring of participants (Indefinite duration)
Links to administrative sources No
Promotion and access
Promotion
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/?term
Access
Terms of data access (charter for data provision, format of data, availability delay) Data may be used by academic teams. Access based on contract collaboration. Data may not be used by industrial teams
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05